Subspecialties: Page 1306

Riverain nets Novation contract

By AuntMinnie.com staff writers

Computer-aided detection (CAD) developer Riverain Medical has signed a multiyear purchasing agreement with group purchasing organization Novation.

January 19, 2006

High resolution, fast acquisition give 3D MRA edge in abdomen

By Shalmali Pal

Three-dimensional contrast-enhanced MR angiography (CEMRA) at 3 tesla is "extremely promising" for evaluating abdominal vasculature, according to researchers from the University of California, Los Angeles. The advantages of 3D CEMRA at 3 tesla include improved spatial resolution and a higher signal-to-noise ratio (SNR).

January 19, 2006

2006 01 13 13 51 42 706

Sectra adds neurorad PACS install

By AuntMinnie.com staff writers

Swedish imaging informatics and digital mammography vendor Sectra has installed its PACS software in a neuroradiology department in Sweden.

January 18, 2006

GE signs Sullivan Orthopedic Associates

By AuntMinnie.com staff writers

GE Healthcare has inked a deal to provide digital x-ray technology to Sullivan Orthopedic Associates in Stoughton, MA.

January 18, 2006

Corindus launches U.S. office

By AuntMinnie.com staff writers

Israeli cardiac cath lab technology developer Corindus has opened a U.S. headquarters in Auburndale, MA. The facility will manage sales, marketing, and clinical affairs in the U.S., according to the Haifa-based firm.

January 18, 2006

Contrast-enhanced US useful for differentiating focal liver lesions

By Radiology Review

(Radiology Review) All three vascular phases should be assessed when sonographic contrast agents are used to differentiate benign from malignant focal liver lesions, according to researchers from Spain. They evaluated the accuracy of tumoral vascularity display in liver tumors using contrast-enhanced sonography.

January 18, 2006

Chemical shift MRI improves detection of adrenal adenomas

By Radiology Review

(Radiology Review) Whether a coexisting adrenal mass is an adenoma or metastasis affects treatment of extra-adrenal primary tumors, according to researchers from Turkey. They report in the American Journal of Roentgenology that chemical shift MRI can help differentiate adrenal adenomas from nonadenomas and metastases.

January 18, 2006

UltraSPECT brings Xpress.cardiac to Europe

By AuntMinnie.com staff writers

Israeli nuclear medicine developer UltraSPECT has completed the first European installation of its Xpress.cardiac package.

January 17, 2006

X-ray planning improves hip replacement surgical outcomes

By Shalmali Pal

Preoperative planning of total hip arthroplasty forces the surgeon to think in three dimensions, which is more likely to mitigate possible complications, such as dislocation or malfunction of the prosthesis. A group of orthopedic surgeons have backed x-ray for step-by-step mapping of hip replacement surgery.

January 17, 2006

Guidant accepts Boston Scientific's offer

By AuntMinnie.com staff writers

The board of directors of interventional device firm Guidant determined today that Boston Scientific's $80 per share acquisition offer was superior to Johnson & Johnson's current agreement to acquire the firm for $73 per share, or $24.2 billion.

January 16, 2006

Thoratec selects Burbach as CEO

Interventional firm Thoratec has named Gary Burbach as its president and CEO.

January 16, 2006

Abbott amends Boston Scientific agreement

By AuntMinnie.com staff writers

Interventional device firm Abbott Laboratories said it has amended its agreement with Boston Scientific to acquire Guidant's vascular business, which is contingent on the closing of Boston Scientific's proposed acquisition of Guidant.

January 16, 2006

Page 1306 of 1583